Notch3 signalling promotes tumour growth in colorectal cancer.

Notch3 signalling promotes tumour growth in colorectal cancer.

Show other versions (1)

Increased Notch1 activity has been observed in intestinal tumours, partially accomplished by β-catenin-mediated up-regulation of the Notch ligand Jagged-1. Whether further mechanisms of Notch activation exist and other Notch receptors might be involved is unclear. Microarray data indicated that Notc...

Bibliografske podrobnosti
Main Authors:	Serafin, V, Persano, L, Moserle, L, Esposito, G, Ghisi, M, Curtarello, M, Bonanno, L, Masiero, M, Ribatti, D, Stürzl, M, Naschberger, E, Croner, R, Jubb, A, Harris, A, Koeppen, H, Amadori, A, Indraccolo, S
Format:	Journal article
Jezik:	English
Izdano:	2011

Podobne knjige/članki

Notch3 signalling promotes tumour growth in colorectal cancer.
od: Serafin, V, et al.
Izdano: (2011)

The Notch ligand Jagged1 as a target for anti-tumour therapy
od: Demin eLi, et al.
Izdano: (2014-09-01)

Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications.
od: Li, J, et al.
Izdano: (2009)

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
od: Jubb, A, et al.
Izdano: (2010)

The notch ligand JAGGED1 as a target for anti-tumor therapy.
od: Li, D, et al.
Izdano: (2014)

Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma
od: Jubb, A, et al.
Izdano: (2012)

Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma.
od: Jubb, A, et al.
Izdano: (2012)

Angiocrine Regulation of Epithelial Barrier Integrity in Inflammatory Bowel Disease
od: Michael Stürzl, et al.
Izdano: (2021-08-01)

One Step Nucleic Acid Amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas
od: Croner Roland S, et al.
Izdano: (2010-09-01)

No NETs no TIME: Crosstalk between neutrophil extracellular traps and the tumor immune microenvironment
od: Qi Fang, et al.
Izdano: (2022-12-01)

Notch signaling: its roles and therapeutic potential in hematological malignancies
od: Gu, Y, et al.
Izdano: (2016)

Role of Notch ligands in tumour angiogenesis
od: Oon, C
Izdano: (2011)

New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis.
od: Oon, C, et al.
Izdano: (2011)

Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer
od: Lisa Perilli, et al.
Izdano: (2019-08-01)

Chemotactic Cues for NOTCH1-Dependent Leukemia
od: Erich Piovan, et al.
Izdano: (2018-04-01)

Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth
od: Oon, C, et al.
Izdano: (2017)

p21-activated kinase 1: PAK'ed with potential.
od: Ong, C, et al.
Izdano: (2011)

Targeting NOTCH1 in combination with antimetabolite drugs prolongs life span in relapsed pediatric and adult T-acute lymphoblastic leukemia xenografts
od: Sonia Minuzzo, et al.
Izdano: (2023-09-01)

Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours
od: P. Fusco, et al.
Izdano: (2019-10-01)

Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts
od: Carolina Venturoli, et al.
Izdano: (2021-02-01)

RHOQ is induced by DLL4 and regulates angiogenesis by determining the intracellular route of the Notch intracellular domain
od: Bridges, E, et al.
Izdano: (2020)

Delta-like 4 - Notch signalling in angiogenesis and tumour biology
od: Shi, W
Izdano: (2007)

Non-canonical NOTCH3 signalling limits tumour angiogenesis
od: Shuheng Lin, et al.
Izdano: (2017-07-01)

Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
od: Giatromanolaki, A, et al.
Izdano: (2007)

Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
od: Giulia Franciosa, et al.
Izdano: (2021-05-01)

Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer.
od: Jubb, A, et al.
Izdano: (2010)

Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.
od: Whiteman, P, et al.
Izdano: (2013)

Notch regulation of tumor angiogenesis.
od: Bridges, E, et al.
Izdano: (2011)

Targeting tumour hypoxia in breast cancer.
od: Milani, M, et al.
Izdano: (2008)

Tumour-derived laminin α5 (LAMA5) promotes colorectal liver metastasis growth, branching angiogenesis and notch pathway inhibition.
od: Gordon-Weeks, A, et al.
Izdano: (2019)

TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study
od: Papadopoulos Thomas, et al.
Izdano: (2007-08-01)

Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts
od: Valentina Agnusdei, et al.
Izdano: (2020-05-01)

Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissues.
od: Anika Klingler, et al.
Izdano: (2020-01-01)

Allelic Imbalance Analysis in Liquid Biopsy to Monitor Locally Advanced Esophageal Cancer Patients During Treatment
od: Elisa Boldrin, et al.
Izdano: (2020-08-01)

Biomarkers to predict the clinical efficacy of bevacizumab in cancer.
od: Jubb, A, et al.
Izdano: (2010)

Reduction of Derlin activity suppresses Notch-dependent tumours in the C. elegans germ line.
od: Ramya Singh, et al.
Izdano: (2021-09-01)

Proline-hydroxylated hypoxia-inducible factor 1a (HIF-1a) upregulation in human tumours
od: Snell, C, et al.
Izdano: (2014)

Thymic Carcinoid Tumour
od: Isabel Parra, et al.
Izdano: (2002-01-01)

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia.
od: Koukourakis, M, et al.
Izdano: (2010)

A new model of Notch signalling: Control of Notch receptor cis-inhibition via Notch ligand dimers.
od: Daipeng Chen, et al.
Izdano: (2023-01-01)